SANES

9.044

+1.72%↑

BBVA

18.275

+1.44%↑

MUV2

540

+1.31%↑

INGA

22.095

+2.03%↑

KBC

105

-0.33%↓

SANES

9.044

+1.72%↑

BBVA

18.275

+1.44%↑

MUV2

540

+1.31%↑

INGA

22.095

+2.03%↑

KBC

105

-0.33%↓

SANES

9.044

+1.72%↑

BBVA

18.275

+1.44%↑

MUV2

540

+1.31%↑

INGA

22.095

+2.03%↑

KBC

105

-0.33%↓

SANES

9.044

+1.72%↑

BBVA

18.275

+1.44%↑

MUV2

540

+1.31%↑

INGA

22.095

+2.03%↑

KBC

105

-0.33%↓

SANES

9.044

+1.72%↑

BBVA

18.275

+1.44%↑

MUV2

540

+1.31%↑

INGA

22.095

+2.03%↑

KBC

105

-0.33%↓

Search

Gimv NV

Abierto

SectorFinanzas

44.25 -5.35

Resumen

Variación precio

24h

Actual

Mínimo

44.1

Máximo

46.95

Métricas clave

By Trading Economics

Ventas

114M

P/B

Media del Sector

5.944

28.864

BPA

2.43

Rentabilidad por dividendo

5.77

Empleados

94

EBITDA

76M

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

5.77%

3.92%

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

1.6B

Apertura anterior

49.6

Cierre anterior

44.25

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

204 / 528 Clasificación en Finance

Gimv NV Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

24 nov 2025, 21:54 UTC

Adquisiciones, fusiones, absorciones

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175 Million

24 nov 2025, 18:26 UTC

Principales Movimientos del Mercado

Tegna Shares Fall After Trump Blasts Proposal to Lift Broadcast Ownership Cap

24 nov 2025, 23:49 UTC

Charlas de Mercado

Nikkei May Rise After Tech Recovery on Wall Street -- Market Talk

24 nov 2025, 23:08 UTC

Charlas de Mercado

More Losses Ahead for Steel & Tube, Says New Bear -- Market Talk

24 nov 2025, 23:08 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

24 nov 2025, 22:56 UTC

Charlas de Mercado
Ganancias

Alimentation Couche-Tard U.S. Sales Gain Momentum -- Market Talk

24 nov 2025, 22:47 UTC

Charlas de Mercado

Kiwi Property Can Keep Growing Its Dividend -- Market Talk

24 nov 2025, 22:36 UTC

Charlas de Mercado
Ganancias

Kiwi Property's 1H Result Cements Bull's Confidence in Outlook -- Market Talk

24 nov 2025, 22:32 UTC

Ganancias

Webco Industries 1Q EPS $6.79 >WEBC

24 nov 2025, 22:07 UTC

Ganancias

Couche-Tard 2Q Canada Same-Store Merchandise Revenues Up 5.4% >ATD.T

24 nov 2025, 22:07 UTC

Ganancias

Couche-Tard 2Q U.S. Same-Store Merchandise Revenues Up 1.2% >ATD.T

24 nov 2025, 22:06 UTC

Ganancias

Couche-Tard 2Q Adj EPS 78c >ATD.T

24 nov 2025, 22:06 UTC

Ganancias

Couche-Tard 2Q Rev $17.9B >ATD.T

24 nov 2025, 22:06 UTC

Ganancias

Couche-Tard 2Q EPS 79c >ATD.T

24 nov 2025, 22:05 UTC

Ganancias

Couche-Tard 2Q Rev $17.9B >ATD.T

24 nov 2025, 22:05 UTC

Ganancias

Couche-Tard 2Q Net $740.6M >ATD.T

24 nov 2025, 22:05 UTC

Ganancias

Couche-Tard 2Q Adj EPS 78c >ATD.T

24 nov 2025, 22:05 UTC

Ganancias

Couche-Tard 2Q EPS 79c >ATD.T

24 nov 2025, 21:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

24 nov 2025, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

24 nov 2025, 21:44 UTC

Charlas de Mercado

Canada Close to MOU With Alberta About New Possible Pipeline -- Market Talk

24 nov 2025, 21:39 UTC

Adquisiciones, fusiones, absorciones

Exodus Agrees to Acquire W3C Corp in Deal Valued at $175M

24 nov 2025, 20:42 UTC

Charlas de Mercado

Oil Futures Snap Three-Session Losing Streak -- Market Talk

24 nov 2025, 20:41 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

24 nov 2025, 19:56 UTC

Adquisiciones, fusiones, absorciones

Nvidia Says It's Not Enron in Private Memo Refuting Accounting Questions -- Barrons.com

24 nov 2025, 18:26 UTC

Charlas de Mercado

Crude Futures Move Higher in Choppy Trade -- Market Talk

24 nov 2025, 17:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

24 nov 2025, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

24 nov 2025, 17:09 UTC

Charlas de Mercado

Brent Could Drop to the $30s Without Production Cuts, JPM Says -- Market Talk

24 nov 2025, 16:52 UTC

Adquisiciones, fusiones, absorciones

Strategy Silent on Bitcoin Holdings. Why It's a Big Deal for the Stock and Cryptos. -- Barrons.com

Comparación entre iguales

Cambio de precio

Gimv NV Esperado

Consenso

By TipRanks

0 ratings

0

Comprar

0

Mantener

0

Vender

Sentimiento

By Acuity

204 / 528 Clasificación en Finanzas

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Gimv NV

Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
help-icon Live chat